Stock Research: Hapvida Participações e Investimentos

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Hapvida Participações e Investimentos

BOVESPA:HAPV3 BRHAPVACNOR4
17
  • Value
    40
  • Growth
    11
  • Safety
    Safety
    83
  • Combined
    43
  • Sentiment
    19
  • 360° View
    360° View
    17
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Hapvida Participacoes e Investimentos SA (Hapvida) is a Brazil-based holding healthcare company. Its main activities include covering medical, hospital, and dental care costs, and providing medical, hospital, dentistry services, examinations, and diagnoses. The company operates in the Northeast of Brazil across more than 10 states. In the last fiscal year, the company had a market cap of $3034 million, profits of $534 million, and revenue of $4680 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 17 (better than 17% compared with alternatives), overall professional sentiment and financial characteristics for the stock Hapvida Participações e Investimentos are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Hapvida Participações e Investimentos. Only the consolidated Value Rank has an attractive rank of 83, which means that the share price of Hapvida Participações e Investimentos is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 83% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 11, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 40, meaning the company has a riskier financing structure than 60% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 81% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 19. ...read more

more
Index
BOVESPA
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
83 81 59 31
Growth
11 61 31 19
Safety
Safety
40 32 1 43
Sentiment
19 33 32 37
360° View
360° View
17 55 9 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 90 89 76
Opinions Change
8 28 31 30
Pro Holdings
n/a 40 20 18
Market Pulse
27 21 17 61
Sentiment
19 33 32 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
83 81 59 31
Growth
11 61 31 19
Safety Safety
40 32 1 43
Combined
43 74 5 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
78 82 45 37
Price vs. Earnings (P/E)
93 93 75 44
Price vs. Book (P/B)
93 97 93 39
Dividend Yield
37 24 10 18
Value
83 81 59 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
51 58 32 87
Profit Growth
8 72 84 13
Capital Growth
53 100 6 1
Stock Returns
5 9 19 15
Growth
11 61 31 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 32 36 34
Refinancing
70 66 27 23
Liquidity
18 16 15 49
Safety Safety
40 32 1 43

Similar Stocks

Discover high‑ranked alternatives to Hapvida Participações e Investimentos and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.